Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface

We have investigated the influence of blood flow on thrombin generation, fibrin formation, and fibrin deposition on procoagulant and nonprocoagulant surfaces. Nonanticoagulated human blood was drawn for 5 minutes directly from an antecubital vein over stimulated endothelial cells expressing tissue factor and over human type III collagen fibrils, positioned in parallel-plate perfusion chambers. The shear rates at these surfaces were 50, 650, and 2,600 s-1. Deposition of platelets and fibrin was measured by morphometry. Thrombin and fibrin formation was determined by measuring prothrombin fragments 1 + 2 (F 1 + 2), thrombin-antithrombin III complexes, (T-AT) and fibrinopeptide A (FPA) in blood effluent from the perfusion chamber at the end of the 5- minute perfusion period. On procoagulant endothelial cells, the thrombi were primarily composed of fibrin. The fibrin deposition (81%, 21%, and 2% at 50, 650, and 2,600 s-1, respectively) and plasma levels of F 1 + 2, T-AT and FPA were shear rate dependent and highest at 50 s-1. There was a positive correlation between F 1 + 2 and T-AT and the fibrin deposition (P < .01). In contrast, the collagen surface triggered primarily thrombi that were composed of platelets. The platelet thrombi and plasma levels of F 1 + 2 and T-AT were also dependent on the shear rate, but highest at 650 and 2,600 s-1. F 1 + 2 and T-AT reached the same level as observed with procoagulant endothelial cells at the higher shear rates. There was a positive correlation between F 1 + 2 and T-AT and the platelet thrombus formation (P < .05), confirming the predominant role of platelets in thrombin generation. Thus, thrombin formation is strongly influenced by the blood flow, and this effect depends on the composition of the thrombogenic surface.

[1]  Y. Nemerson,et al.  Modulation of procoagulant activity of extracellular endothelial matrix by anti‐tissue factor antibody and the synthetic peptide Arg‐Gly‐Asp‐Val. Experiments with flowing nonanticoagulated human blood , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[2]  W. Bode,et al.  Spatial Structure of Thrombin as a Guide to Its Multiple Sites of Interaction , 1993, Seminars in thrombosis and hemostasis.

[3]  Y. Nemerson,et al.  The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions. , 1993, Blood.

[4]  S. Rapaport,et al.  Initiation and regulation of tissue factor-dependent blood coagulation. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  Y. Nemerson,et al.  The Effect of Flow on Hemostasis and Thrombosis , 1991, Thrombosis and Haemostasis.

[6]  H. Weiss,et al.  Upstream Thrombus Growth Impairs Downstream Thrombogenesis in Non-Anticoagulated Blood: Effect of Procoagulant Artery Subendothelium and Non-Procoagulant Collagen , 1991, Thrombosis and Haemostasis.

[7]  J. Sixma,et al.  Quantification of fibrin deposition in flowing blood with peroxidase-labeled fibrinogen. High shear rates induce decreased fibrin deposition and appearance of fibrin monomers. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  H. Baumgartner,et al.  Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin. , 1990, Arteriosclerosis.

[9]  H. Baumgartner,et al.  Procoagulant activity of endotoxin-treated human endothelial cells exposed to native human flowing blood , 1989 .

[10]  H. Baumgartner,et al.  Axial Dependence of Platelet‐Collagen Interactions in Flowing Blood: Upstream Thrombus Growth Impairs Downstream Platelet Adhesion , 1989, Arteriosclerosis.

[11]  S. Hanson,et al.  Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Markwardt Pharmacological Approaches to Thrombin Regulation , 1986, Annals of the New York Academy of Sciences.

[13]  H. Weiss,et al.  Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects. , 1986, The Journal of clinical investigation.

[14]  W. Fiers,et al.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Esmon,et al.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[17]  K. Sakariassen,et al.  Ex Vivo Models for Studying Thrombosis: Special Emphasis on Shear Rate Dependent Blood-Collagen Interactions , 1992 .

[18]  J. Sixma,et al.  Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant. , 1990, Arteriosclerosis.

[19]  H. Baumgartner,et al.  Measurements of platelet interaction with components of the vessel wall in flowing blood. , 1989, Methods in enzymology.

[20]  C. Esmon,et al.  Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. , 1987, The Journal of clinical investigation.